Business

NOHO, INC. ANNOUNCES ITS INTENT TO RAISE UP TO $20 MILLION THROUGH A REGULATION A TIER II OFFERING

NOHO, INC. ANNOUNCES ITS INTENT TO RAISE UP TO $20 MILLION THROUGH A REGULATION A TIER II OFFERING.

articleNoho, Inc.September 30, 20214/company/noho-inc/news/noho-inc-announces-its-intent-to-raise-up-to-dollar20-million-through-a-regulation-a-tier-ii-offering
NOHO, INC. ANNOUNCES ITS INTENT TO RAISE UP TO $20 MILLION THROUGH A REGULATION A TIER II OFFERING

About this update from Noho, Inc.

[{"type":"text","content":"\n Scottsdale, Arizona , Sept. 30, 2021 (GLOBE NEWSWIRE) -- NOHO, Inc. (OTC PINK: DRNK), a Wyoming corporation (the “Company”), announced the following: The Company intends to raise up to $20 million through a Regulation A Tier II Offering (“Offering”). The proceeds from the offering will be used for brand development and advertising spend as well as general operations.  A portion of funding, if available, will also be reserved for acquisition. After a previous successful transaction with Continuation Capital for the sale of debt with Sibannac, Inc., the firm is expected to issue NOHO a written Indication of Interest in the Offering up to $8 million.  The balance of the raise will be allocated between existing shareholders and other institutional and private investors.  The Company will be working with its auditor to complete the necessary audits for the Offering. Offering details, including proposed share pricing, will be disclosed upon filing the registration documents. Product and Operations Update While Direct to Consumer remains the primary sales model, as part of the product roll-out plan the Company will be focusing resources in Las Vegas and New York for brand awareness and partnership opportunities.  The Company has provided a product development agreement to a Las Vegas-based gaming influencer with a substantial social media following, for a beverage additive.  NOHO will handling all formulation and product design responsibility.  Consummation of the agreement is expected within a week.  The sample product featured on Twitter is a new formulation in the nootropics category.  Nootropics are compounds that enhance cognitive performance.  This formulation contains only natural, dietary supplements and would not be subject to FDA approval. The Company will be providing more information on this product in the near future. Warrants The warrant compensation for the transaction with Sibannac, Inc. is in final stages of determination and will be announced through a joint release upon completion.    More from NOHO – In addition to the After Shot, we have developed a new line of products, all leveraging Hydro-Nano technology, which will be rolling out soon.  For additional information and product updates, please follow us at www.nohosho...

More updates from Noho, Inc.